Product information and disease descriptionProduct descriptionProduct information
Indication
4 evidence topics · 4 sources
Indication under development: adults with generalized anxiety disorder
Labeling scope sought and filing strategy across generalized anxiety disorder and major depressive disorder
Other indications in development: major depressive disorder and posttraumatic stress disorder
Proposed labeled indication submitted to a regulator
No evidence found.